Lv2
149 积分 2025-10-28 加入
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
8天前
已完结
The story of amylin: from physiology to therapy
8天前
已完结
PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy
1个月前
已完结
KAT6 inhibitors under investigation for solid tumors: the preclinical and early phase progress
1个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
1个月前
已完结
A genome-wide CRISPR-based screen identifies KAT7 as a driver of cellular senescence
2个月前
已完结
Research progress on the role and inhibitors of Keap1 signaling pathway in inflammation
3个月前
已完结
Direct small-molecule inhibitors of the Keap1-Nrf2 protein-protein interaction: Scaffold evolution, PROTAC strategies, and therapeutic implications
3个月前
已完结
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2
5个月前
已完结
皖公网安备34019202002308
